Diagnosis of alterations of serum calcium metabolism

Medicinal Chemistry

Volumn 8, Issue 4, 2012, Pages 551-555

  Lumachi, Franco ^a   Cappelletti, Piero ^b   Tozzoli, Renato ^c   Basso, Stafano M M ^c   Luisetto, Giovanni ^a   Camozzi, Valentina ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c S MARIA DEGLI ANGELI HOSPITAL   (Italy)

Author keywords

Calcium metabolism; Calciuria; Hypercalcemia; PTH; PTHrP; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM; LITHIUM; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN;

ARTICLE; BIPOLAR DISORDER; BONE; CALCIUM METABOLISM; CLINICAL EVALUATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HYPERCALCEMIA; IMMOBILIZATION; INTESTINE; KIDNEY; KIDNEY FUNCTION; PARATHYROID CARCINOMA; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL;

CALCIUM; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERCALCEMIA;

EID: 84863758262     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340612801216139     Document Type: Article

References (29)

1. nd ed.; AACC Press: Washington, DC, 2009.
2. Landeson, J. H.; Lewis, J. W.; Boyd, J. C. Failure of total calcium corrected for protein, albumin, and pH to correctly assess free calcium status. J. Clin. Endocrinol. Metab., 1978, 46, 986-993.
3. Clase, C. M.; Norman, G. L.; Beecroft, M. L.; Churchill, D. N. Albumincorrected calcium and ionized calcium in stable haemodialysis patients. Nephrol. Dial. Transplant., 2000, 15, 1841-1846.
4. Slomp, J.; van der Voort P. H. J.; Gerritsen, R. T.; Berk, J. A. M.; Bakker, A. J. Albumin-adjusted calcium is not suitable for diagnosis of hyper-and hypocalcemia in the critically ill. Crit. Care Med., 2003, 31, 1389-1393.
5. nd ed.; CLSI: Wayne, PA, 2005.
6. th ed.; WB Saunders Company: St. Louis, MO, 2006.
7. Calvi, L. M.; Bushinsky, D. A. When is it appropriate to order ionized calcium? J. Am. Soc. Nephrol., 2008, 19, 1257-1260.
8. Bilezikian, J. P.; Potts, J. T. Jr.; Fuleihan, Gel-H.; Kleerekoper, M.; Neer, R.; Peacock, M.; Rastad, J.; Silverberg, S. J.; Udelsman, R.; Wells, S. A. Summary statement from a Workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J. Clin. Endocrinol. Metab., 2002, 87, 5353-5361.
9. Cappelletti, P.; Tozzoli, R. In: Hypercalcemia Pathophysiology & Treatment; Lumachi, F. & Basso, S. M. M., Eds.; Bentham Science: Sharjah (UAE), 2010; pp. 45-61.
10. Toke, J.; Patócs, A.; Balogh, K.; Balogh, K.; Gergics, P.; Stenczer, B.; Rácz, K.; Tóth. M. Parathyroid hormone-dependent hypercalcemia. Wien. Klin. Wochenschhr., 2009, 121, 236-245.
11. Okamoto, T.; Iihara, M.; Obara, T.; Tsukada, T. Parathyroid carcinoma: etiology, diagnosis, and treatment. World J. Surg., 2009, 33, 2343-2354.
12. Lumachi, F.; Basso, S. M. M.; Basso, U. Parathyroid cancer: etiology, clinical presentation and treatment. Anticancer Res., 2006, 26, 4803-4808.
13. Lumachi, F.; Tregnaghi, A.; Zucchetta, P.; Marzola, M. C.; Cecchin, D.; Marchesi, P.; Fallo, F., Bui, F. Technetium-99m sestamibi scintigraphy and helical CT together in patients with primary hyperparathyroidism: a prospective clinical study. Brit. J. Radiol., 2004, 77, 100-103.
14. Younes, N. A.; Shafagoj, Y.; Khatib, F.; Ababneh, M. Laboratory screening for hyperparathyroidism. Clin. Chim. Acta, 2005, 353, 1-12.
15. Lumachi, F.; Brunello, A.; Roma, A.; Basso, U. Cancer-induced hypercalcemia. Anticancer Res., 2009, 29, 1551-1556.
16. Bilezikian, J. P.; Khan, A. A.; Potts, J. T. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J. Clin. Endocrinol. Metab., 2009, 94, 335-339.
17. Friedman, P. A.; Goodman, W. G. PTH (1-84)/PTH (7-84): a balance of power. Am. J. Physiol. Renal Physiol., 2006, 290, F975-F984.
18. D'Amour, P. Circulating PTH molecular forms: what we know and what we don't. Kidney Int., 2006, 102(Suppl. 1), S29-S33.
19. Cole, D. E.; Webb, S.; Chan, P. C. Update on parathyroid hormone: new tests and new challenges for external quality assessment. Clin. Biochem., 2007, 40, 585-590.
20. Viljoen, A.; Singh, D. K.; Twomey, P. J.; Farrington, K. Analytical quality goals for parathyroid hormone based on biological variation. Clin. Chem. Lab. Med., 2008, 46, 1438-1442.
21. Joly, D.; Drueke, T. B.; Alberti, C.; Houillier, P.; Lawson-Body, E.; Martin, K. J.; Massart, C.; Moe, S. M.; Monge, M.; Souberbielle, J. C. Variation in serum and plasma PTH levels in secondgeneration assays in hemodialysis patients: a cross-sectional study. Am. J. Kidney Dis., 2008, 51, 987-995.
22. Eastell, R.; Arnold, A.; Brandi, M. L.; Brown, E. M.; D'Amour, P.; Hanley, D. A.; Rao, D. S.; Rubin, M. R.; Goltzman, D.; Silverberg, S. J.; Marx, S. J.; Peacock, M.; Mosekilde, L.; Bouillon, R.; Lewiecki, E. M. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J. Clin. Endocrinol. Metab., 2009, 94, 340-530.
23. Dawson-Hughes, B.; Heaney, R. P.; Holick, M. F.; Lips, P.; Meunier, P. J.; Vieth, R. Estimates of optimal vitamin D status. Osteoporosis Int., 2005, 16, 713-716.
24. Phinney, K. W. Development of a standard reference material for vitamin D in serum. Am. J. Clin. Nutr., 2008, 88(suppl), 511S-512S.
25. Bischoff-Ferrari, H. A. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv. Exp. Med. Biol., 2008, 624, 55-71.
26. Fritchie, K.; Zedek, D.; Grenache, D. G. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia. Clin. Chim. Acta.; 2009, 402, 146-149.
27. Reginster, J.-Y.; Collette, J.; Neuprez, A.; Zegels, B.; Deroisy, R.; Bruyere, O. Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy. Bone, 2008, 42, 832-836.
28. Lumachi, F.; Ermani, M.; Camozzi, V.; Tombolan, V.; Luisetto, G. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis. Ann. N. Y. Acad. Sci., 2009, 1173, E60-E63.
29. Lewiecki, E. M. Benefits and limitations of bone mineral density and bone turnover markers to monitoring patients treated for osteoporosis. Curr. Osteoporos. Rep., 2010, 8, 15-22.